 | • レポートコード：QFJ1-3872 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、自己免疫性肝炎治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、注射剤、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・自己免疫性肝炎治療の市場動向 ・企業の競争状況、市場シェア ・自己免疫性肝炎治療の種類別市場規模と予測2016-2027（錠剤、注射剤、その他） ・自己免疫性肝炎治療の用途別市場規模と予測2016-2027（病院、診療所、その他） ・自己免疫性肝炎治療の北米市場規模2016-2027（アメリカ、カナダ） ・自己免疫性肝炎治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・自己免疫性肝炎治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・自己免疫性肝炎治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・自己免疫性肝炎治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Gilead Sciences, Inc.、Acorda Therapeutics, Inc.、Allergan & Novartis、Intercept Pharmaceuticals, Inc.、Hightidetx、Shire Plc.、NGM Biopharmaceuticals, Inc.、EA Pharma、BiomX、CymaBay Therapeutics、Conatus Pharmaceuticals, Inc.、Durect Corporation、Sirnaomics, Inc.、Shenzhen HighTide Biopharmaceuticals Ltd.） ・結論 |
Autoimmune Hepatitis is a serious condition that may worsen over time if not treated. Autoimmune Hepatitis can lead to cirrhosis and liver failure.Autoimmune hepatitis is a disease in which the body’s own immune system attacks the liver and causes it to become inflamed.
Market Analysis and Insights: Global Autoimmune Hepatitis Treatment Market
The global Autoimmune Hepatitis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Autoimmune Hepatitis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Autoimmune Hepatitis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Autoimmune Hepatitis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Autoimmune Hepatitis Treatment market.
Global Autoimmune Hepatitis Treatment Scope and Market Size
Autoimmune Hepatitis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Autoimmune Hepatitis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Table Product
Inject Product
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Gilead Sciences, Inc.
Acorda Therapeutics, Inc.
Allergan & Novartis
Intercept Pharmaceuticals, Inc.
Hightidetx
Shire Plc.
NGM Biopharmaceuticals, Inc.
EA Pharma
BiomX
CymaBay Therapeutics
Conatus Pharmaceuticals, Inc.
Durect Corporation
Sirnaomics, Inc.
Shenzhen HighTide Biopharmaceuticals Ltd.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autoimmune Hepatitis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Table Product
1.2.3 Inject Product
1.2.4 Others
1.3 Market by Application
1.3.1 Global Autoimmune Hepatitis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Autoimmune Hepatitis Treatment Market Perspective (2016-2027)
2.2 Autoimmune Hepatitis Treatment Growth Trends by Regions
2.2.1 Autoimmune Hepatitis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Autoimmune Hepatitis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Autoimmune Hepatitis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Autoimmune Hepatitis Treatment Industry Dynamic
2.3.1 Autoimmune Hepatitis Treatment Market Trends
2.3.2 Autoimmune Hepatitis Treatment Market Drivers
2.3.3 Autoimmune Hepatitis Treatment Market Challenges
2.3.4 Autoimmune Hepatitis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Autoimmune Hepatitis Treatment Players by Revenue
3.1.1 Global Top Autoimmune Hepatitis Treatment Players by Revenue (2016-2021)
3.1.2 Global Autoimmune Hepatitis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Autoimmune Hepatitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Autoimmune Hepatitis Treatment Revenue
3.4 Global Autoimmune Hepatitis Treatment Market Concentration Ratio
3.4.1 Global Autoimmune Hepatitis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Hepatitis Treatment Revenue in 2020
3.5 Autoimmune Hepatitis Treatment Key Players Head office and Area Served
3.6 Key Players Autoimmune Hepatitis Treatment Product Solution and Service
3.7 Date of Enter into Autoimmune Hepatitis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Autoimmune Hepatitis Treatment Breakdown Data by Type
4.1 Global Autoimmune Hepatitis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Autoimmune Hepatitis Treatment Forecasted Market Size by Type (2022-2027)
5 Autoimmune Hepatitis Treatment Breakdown Data by Application
5.1 Global Autoimmune Hepatitis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Autoimmune Hepatitis Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Autoimmune Hepatitis Treatment Market Size (2016-2027)
6.2 North America Autoimmune Hepatitis Treatment Market Size by Type
6.2.1 North America Autoimmune Hepatitis Treatment Market Size by Type (2016-2021)
6.2.2 North America Autoimmune Hepatitis Treatment Market Size by Type (2022-2027)
6.2.3 North America Autoimmune Hepatitis Treatment Market Size by Type (2016-2027)
6.3 North America Autoimmune Hepatitis Treatment Market Size by Application
6.3.1 North America Autoimmune Hepatitis Treatment Market Size by Application (2016-2021)
6.3.2 North America Autoimmune Hepatitis Treatment Market Size by Application (2022-2027)
6.3.3 North America Autoimmune Hepatitis Treatment Market Size by Application (2016-2027)
6.4 North America Autoimmune Hepatitis Treatment Market Size by Country
6.4.1 North America Autoimmune Hepatitis Treatment Market Size by Country (2016-2021)
6.4.2 North America Autoimmune Hepatitis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Autoimmune Hepatitis Treatment Market Size (2016-2027)
7.2 Europe Autoimmune Hepatitis Treatment Market Size by Type
7.2.1 Europe Autoimmune Hepatitis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Autoimmune Hepatitis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Autoimmune Hepatitis Treatment Market Size by Type (2016-2027)
7.3 Europe Autoimmune Hepatitis Treatment Market Size by Application
7.3.1 Europe Autoimmune Hepatitis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Autoimmune Hepatitis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Autoimmune Hepatitis Treatment Market Size by Application (2016-2027)
7.4 Europe Autoimmune Hepatitis Treatment Market Size by Country
7.4.1 Europe Autoimmune Hepatitis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Autoimmune Hepatitis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Autoimmune Hepatitis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Autoimmune Hepatitis Treatment Market Size by Type
8.2.1 Asia-Pacific Autoimmune Hepatitis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Autoimmune Hepatitis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Autoimmune Hepatitis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Autoimmune Hepatitis Treatment Market Size by Application
8.3.1 Asia-Pacific Autoimmune Hepatitis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Autoimmune Hepatitis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Autoimmune Hepatitis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Autoimmune Hepatitis Treatment Market Size by Region
8.4.1 Asia-Pacific Autoimmune Hepatitis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Autoimmune Hepatitis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Autoimmune Hepatitis Treatment Market Size (2016-2027)
9.2 Latin America Autoimmune Hepatitis Treatment Market Size by Type
9.2.1 Latin America Autoimmune Hepatitis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Autoimmune Hepatitis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Autoimmune Hepatitis Treatment Market Size by Type (2016-2027)
9.3 Latin America Autoimmune Hepatitis Treatment Market Size by Application
9.3.1 Latin America Autoimmune Hepatitis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Autoimmune Hepatitis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Autoimmune Hepatitis Treatment Market Size by Application (2016-2027)
9.4 Latin America Autoimmune Hepatitis Treatment Market Size by Country
9.4.1 Latin America Autoimmune Hepatitis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Autoimmune Hepatitis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Autoimmune Hepatitis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Autoimmune Hepatitis Treatment Market Size by Type
10.2.1 Middle East & Africa Autoimmune Hepatitis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Autoimmune Hepatitis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Autoimmune Hepatitis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Autoimmune Hepatitis Treatment Market Size by Application
10.3.1 Middle East & Africa Autoimmune Hepatitis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Autoimmune Hepatitis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Autoimmune Hepatitis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Autoimmune Hepatitis Treatment Market Size by Country
10.4.1 Middle East & Africa Autoimmune Hepatitis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Autoimmune Hepatitis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Gilead Sciences, Inc.
11.1.1 Gilead Sciences, Inc. Company Details
11.1.2 Gilead Sciences, Inc. Business Overview
11.1.3 Gilead Sciences, Inc. Autoimmune Hepatitis Treatment Introduction
11.1.4 Gilead Sciences, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2016-2021)
11.1.5 Gilead Sciences, Inc. Recent Development
11.2 Acorda Therapeutics, Inc.
11.2.1 Acorda Therapeutics, Inc. Company Details
11.2.2 Acorda Therapeutics, Inc. Business Overview
11.2.3 Acorda Therapeutics, Inc. Autoimmune Hepatitis Treatment Introduction
11.2.4 Acorda Therapeutics, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2016-2021)
11.2.5 Acorda Therapeutics, Inc. Recent Development
11.3 Allergan & Novartis
11.3.1 Allergan & Novartis Company Details
11.3.2 Allergan & Novartis Business Overview
11.3.3 Allergan & Novartis Autoimmune Hepatitis Treatment Introduction
11.3.4 Allergan & Novartis Revenue in Autoimmune Hepatitis Treatment Business (2016-2021)
11.3.5 Allergan & Novartis Recent Development
11.4 Intercept Pharmaceuticals, Inc.
11.4.1 Intercept Pharmaceuticals, Inc. Company Details
11.4.2 Intercept Pharmaceuticals, Inc. Business Overview
11.4.3 Intercept Pharmaceuticals, Inc. Autoimmune Hepatitis Treatment Introduction
11.4.4 Intercept Pharmaceuticals, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2016-2021)
11.4.5 Intercept Pharmaceuticals, Inc. Recent Development
11.5 Hightidetx
11.5.1 Hightidetx Company Details
11.5.2 Hightidetx Business Overview
11.5.3 Hightidetx Autoimmune Hepatitis Treatment Introduction
11.5.4 Hightidetx Revenue in Autoimmune Hepatitis Treatment Business (2016-2021)
11.5.5 Hightidetx Recent Development
11.6 Shire Plc.
11.6.1 Shire Plc. Company Details
11.6.2 Shire Plc. Business Overview
11.6.3 Shire Plc. Autoimmune Hepatitis Treatment Introduction
11.6.4 Shire Plc. Revenue in Autoimmune Hepatitis Treatment Business (2016-2021)
11.6.5 Shire Plc. Recent Development
11.7 NGM Biopharmaceuticals, Inc.
11.7.1 NGM Biopharmaceuticals, Inc. Company Details
11.7.2 NGM Biopharmaceuticals, Inc. Business Overview
11.7.3 NGM Biopharmaceuticals, Inc. Autoimmune Hepatitis Treatment Introduction
11.7.4 NGM Biopharmaceuticals, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2016-2021)
11.7.5 NGM Biopharmaceuticals, Inc. Recent Development
11.8 EA Pharma
11.8.1 EA Pharma Company Details
11.8.2 EA Pharma Business Overview
11.8.3 EA Pharma Autoimmune Hepatitis Treatment Introduction
11.8.4 EA Pharma Revenue in Autoimmune Hepatitis Treatment Business (2016-2021)
11.8.5 EA Pharma Recent Development
11.9 BiomX
11.9.1 BiomX Company Details
11.9.2 BiomX Business Overview
11.9.3 BiomX Autoimmune Hepatitis Treatment Introduction
11.9.4 BiomX Revenue in Autoimmune Hepatitis Treatment Business (2016-2021)
11.9.5 BiomX Recent Development
11.10 CymaBay Therapeutics
11.10.1 CymaBay Therapeutics Company Details
11.10.2 CymaBay Therapeutics Business Overview
11.10.3 CymaBay Therapeutics Autoimmune Hepatitis Treatment Introduction
11.10.4 CymaBay Therapeutics Revenue in Autoimmune Hepatitis Treatment Business (2016-2021)
11.10.5 CymaBay Therapeutics Recent Development
11.11 Conatus Pharmaceuticals, Inc.
11.11.1 Conatus Pharmaceuticals, Inc. Company Details
11.11.2 Conatus Pharmaceuticals, Inc. Business Overview
11.11.3 Conatus Pharmaceuticals, Inc. Autoimmune Hepatitis Treatment Introduction
11.11.4 Conatus Pharmaceuticals, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2016-2021)
11.11.5 Conatus Pharmaceuticals, Inc. Recent Development
11.12 Durect Corporation
11.12.1 Durect Corporation Company Details
11.12.2 Durect Corporation Business Overview
11.12.3 Durect Corporation Autoimmune Hepatitis Treatment Introduction
11.12.4 Durect Corporation Revenue in Autoimmune Hepatitis Treatment Business (2016-2021)
11.12.5 Durect Corporation Recent Development
11.13 Sirnaomics, Inc.
11.13.1 Sirnaomics, Inc. Company Details
11.13.2 Sirnaomics, Inc. Business Overview
11.13.3 Sirnaomics, Inc. Autoimmune Hepatitis Treatment Introduction
11.13.4 Sirnaomics, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2016-2021)
11.13.5 Sirnaomics, Inc. Recent Development
11.14 Shenzhen HighTide Biopharmaceuticals Ltd.
11.14.1 Shenzhen HighTide Biopharmaceuticals Ltd. Company Details
11.14.2 Shenzhen HighTide Biopharmaceuticals Ltd. Business Overview
11.14.3 Shenzhen HighTide Biopharmaceuticals Ltd. Autoimmune Hepatitis Treatment Introduction
11.14.4 Shenzhen HighTide Biopharmaceuticals Ltd. Revenue in Autoimmune Hepatitis Treatment Business (2016-2021)
11.14.5 Shenzhen HighTide Biopharmaceuticals Ltd. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Autoimmune Hepatitis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Table Product
Table 3. Key Players of Inject Product
Table 4. Key Players of Others
Table 5. Global Autoimmune Hepatitis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Autoimmune Hepatitis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Autoimmune Hepatitis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Autoimmune Hepatitis Treatment Market Share by Regions (2016-2021)
Table 9. Global Autoimmune Hepatitis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Autoimmune Hepatitis Treatment Market Share by Regions (2022-2027)
Table 11. Autoimmune Hepatitis Treatment Market Trends
Table 12. Autoimmune Hepatitis Treatment Market Drivers
Table 13. Autoimmune Hepatitis Treatment Market Challenges
Table 14. Autoimmune Hepatitis Treatment Market Restraints
Table 15. Global Autoimmune Hepatitis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Autoimmune Hepatitis Treatment Market Share by Players (2016-2021)
Table 17. Global Top Autoimmune Hepatitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Hepatitis Treatment as of 2020)
Table 18. Ranking of Global Top Autoimmune Hepatitis Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Autoimmune Hepatitis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Autoimmune Hepatitis Treatment Product Solution and Service
Table 22. Date of Enter into Autoimmune Hepatitis Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Autoimmune Hepatitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Autoimmune Hepatitis Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Autoimmune Hepatitis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Autoimmune Hepatitis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Autoimmune Hepatitis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Autoimmune Hepatitis Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Autoimmune Hepatitis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Autoimmune Hepatitis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Autoimmune Hepatitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Autoimmune Hepatitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Autoimmune Hepatitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Autoimmune Hepatitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Autoimmune Hepatitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Autoimmune Hepatitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Autoimmune Hepatitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Autoimmune Hepatitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Autoimmune Hepatitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Autoimmune Hepatitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Autoimmune Hepatitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Autoimmune Hepatitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Autoimmune Hepatitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Autoimmune Hepatitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Autoimmune Hepatitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Autoimmune Hepatitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Autoimmune Hepatitis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Autoimmune Hepatitis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Autoimmune Hepatitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Autoimmune Hepatitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Autoimmune Hepatitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Autoimmune Hepatitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Autoimmune Hepatitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Autoimmune Hepatitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Autoimmune Hepatitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Autoimmune Hepatitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Autoimmune Hepatitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Autoimmune Hepatitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Autoimmune Hepatitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Autoimmune Hepatitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Gilead Sciences, Inc. Company Details
Table 63. Gilead Sciences, Inc. Business Overview
Table 64. Gilead Sciences, Inc. Autoimmune Hepatitis Treatment Product
Table 65. Gilead Sciences, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2016-2021) & (US$ Million)
Table 66. Gilead Sciences, Inc. Recent Development
Table 67. Acorda Therapeutics, Inc. Company Details
Table 68. Acorda Therapeutics, Inc. Business Overview
Table 69. Acorda Therapeutics, Inc. Autoimmune Hepatitis Treatment Product
Table 70. Acorda Therapeutics, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2016-2021) & (US$ Million)
Table 71. Acorda Therapeutics, Inc. Recent Development
Table 72. Allergan & Novartis Company Details
Table 73. Allergan & Novartis Business Overview
Table 74. Allergan & Novartis Autoimmune Hepatitis Treatment Product
Table 75. Allergan & Novartis Revenue in Autoimmune Hepatitis Treatment Business (2016-2021) & (US$ Million)
Table 76. Allergan & Novartis Recent Development
Table 77. Intercept Pharmaceuticals, Inc. Company Details
Table 78. Intercept Pharmaceuticals, Inc. Business Overview
Table 79. Intercept Pharmaceuticals, Inc. Autoimmune Hepatitis Treatment Product
Table 80. Intercept Pharmaceuticals, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2016-2021) & (US$ Million)
Table 81. Intercept Pharmaceuticals, Inc. Recent Development
Table 82. Hightidetx Company Details
Table 83. Hightidetx Business Overview
Table 84. Hightidetx Autoimmune Hepatitis Treatment Product
Table 85. Hightidetx Revenue in Autoimmune Hepatitis Treatment Business (2016-2021) & (US$ Million)
Table 86. Hightidetx Recent Development
Table 87. Shire Plc. Company Details
Table 88. Shire Plc. Business Overview
Table 89. Shire Plc. Autoimmune Hepatitis Treatment Product
Table 90. Shire Plc. Revenue in Autoimmune Hepatitis Treatment Business (2016-2021) & (US$ Million)
Table 91. Shire Plc. Recent Development
Table 92. NGM Biopharmaceuticals, Inc. Company Details
Table 93. NGM Biopharmaceuticals, Inc. Business Overview
Table 94. NGM Biopharmaceuticals, Inc. Autoimmune Hepatitis Treatment Product
Table 95. NGM Biopharmaceuticals, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2016-2021) & (US$ Million)
Table 96. NGM Biopharmaceuticals, Inc. Recent Development
Table 97. EA Pharma Company Details
Table 98. EA Pharma Business Overview
Table 99. EA Pharma Revenue in Autoimmune Hepatitis Treatment Business (2016-2021) & (US$ Million)
Table 100. EA Pharma Recent Development
Table 101. BiomX Company Details
Table 102. BiomX Business Overview
Table 103. BiomX Autoimmune Hepatitis Treatment Product
Table 104. BiomX Revenue in Autoimmune Hepatitis Treatment Business (2016-2021) & (US$ Million)
Table 105. BiomX Recent Development
Table 106. CymaBay Therapeutics Company Details
Table 107. CymaBay Therapeutics Business Overview
Table 108. CymaBay Therapeutics Autoimmune Hepatitis Treatment Product
Table 109. CymaBay Therapeutics Revenue in Autoimmune Hepatitis Treatment Business (2016-2021) & (US$ Million)
Table 110. CymaBay Therapeutics Recent Development
Table 111. Conatus Pharmaceuticals, Inc. Company Details
Table 112. Conatus Pharmaceuticals, Inc. Business Overview
Table 113. Conatus Pharmaceuticals, Inc. Autoimmune Hepatitis Treatment Product
Table 114. Conatus Pharmaceuticals, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2016-2021) & (US$ Million)
Table 115. Conatus Pharmaceuticals, Inc. Recent Development
Table 116. Durect Corporation Company Details
Table 117. Durect Corporation Business Overview
Table 118. Durect Corporation Autoimmune Hepatitis Treatment Product
Table 119. Durect Corporation Revenue in Autoimmune Hepatitis Treatment Business (2016-2021) & (US$ Million)
Table 120. Durect Corporation Recent Development
Table 121. Sirnaomics, Inc. Company Details
Table 122. Sirnaomics, Inc. Business Overview
Table 123. Sirnaomics, Inc. Autoimmune Hepatitis Treatment Product
Table 124. Sirnaomics, Inc. Revenue in Autoimmune Hepatitis Treatment Business (2016-2021) & (US$ Million)
Table 125. Sirnaomics, Inc. Recent Development
Table 126. Shenzhen HighTide Biopharmaceuticals Ltd. Company Details
Table 127. Shenzhen HighTide Biopharmaceuticals Ltd. Business Overview
Table 128. Shenzhen HighTide Biopharmaceuticals Ltd. Autoimmune Hepatitis Treatment Product
Table 129. Shenzhen HighTide Biopharmaceuticals Ltd. Revenue in Autoimmune Hepatitis Treatment Business (2016-2021) & (US$ Million)
Table 130. Shenzhen HighTide Biopharmaceuticals Ltd. Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autoimmune Hepatitis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Table Product Features
Figure 3. Inject Product Features
Figure 4. Others Features
Figure 5. Global Autoimmune Hepatitis Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. Autoimmune Hepatitis Treatment Report Years Considered
Figure 10. Global Autoimmune Hepatitis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Autoimmune Hepatitis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Autoimmune Hepatitis Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Autoimmune Hepatitis Treatment Market Share by Regions (2022-2027)
Figure 14. Global Autoimmune Hepatitis Treatment Market Share by Players in 2020
Figure 15. Global Top Autoimmune Hepatitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Hepatitis Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Autoimmune Hepatitis Treatment Revenue in 2020
Figure 17. Global Autoimmune Hepatitis Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Autoimmune Hepatitis Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Autoimmune Hepatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Autoimmune Hepatitis Treatment Market Share by Type (2016-2027)
Figure 21. North America Autoimmune Hepatitis Treatment Market Share by Application (2016-2027)
Figure 22. North America Autoimmune Hepatitis Treatment Market Share by Country (2016-2027)
Figure 23. United States Autoimmune Hepatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Autoimmune Hepatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Autoimmune Hepatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Autoimmune Hepatitis Treatment Market Share by Type (2016-2027)
Figure 27. Europe Autoimmune Hepatitis Treatment Market Share by Application (2016-2027)
Figure 28. Europe Autoimmune Hepatitis Treatment Market Share by Country (2016-2027)
Figure 29. Germany Autoimmune Hepatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Autoimmune Hepatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Autoimmune Hepatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Autoimmune Hepatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Autoimmune Hepatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Autoimmune Hepatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Autoimmune Hepatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Autoimmune Hepatitis Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Autoimmune Hepatitis Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Autoimmune Hepatitis Treatment Market Share by Region (2016-2027)
Figure 39. China Autoimmune Hepatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Autoimmune Hepatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Autoimmune Hepatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Autoimmune Hepatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Autoimmune Hepatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Autoimmune Hepatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Autoimmune Hepatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Autoimmune Hepatitis Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Autoimmune Hepatitis Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Autoimmune Hepatitis Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Autoimmune Hepatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Autoimmune Hepatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Autoimmune Hepatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Autoimmune Hepatitis Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Autoimmune Hepatitis Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Autoimmune Hepatitis Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Autoimmune Hepatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Autoimmune Hepatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Autoimmune Hepatitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Gilead Sciences, Inc. Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2016-2021)
Figure 59. Acorda Therapeutics, Inc. Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2016-2021)
Figure 60. Allergan & Novartis Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2016-2021)
Figure 61. Intercept Pharmaceuticals, Inc. Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2016-2021)
Figure 62. Hightidetx Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2016-2021)
Figure 63. Shire Plc. Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2016-2021)
Figure 64. NGM Biopharmaceuticals, Inc. Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2016-2021)
Figure 65. EA Pharma Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2016-2021)
Figure 66. BiomX Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2016-2021)
Figure 67. CymaBay Therapeutics Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2016-2021)
Figure 68. Conatus Pharmaceuticals, Inc. Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2016-2021)
Figure 69. Durect Corporation Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2016-2021)
Figure 70. Sirnaomics, Inc. Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2016-2021)
Figure 71. Shenzhen HighTide Biopharmaceuticals Ltd. Revenue Growth Rate in Autoimmune Hepatitis Treatment Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
自己免疫性肝炎治療のグローバル市場：規模・現状・予測2019-2025 Autoimmune Hepatitis is a serious condition that may worsen over time if not treated. Autoimmune Hepatitis can lead to cirrhosis and liver failure.Autoimmune hepatitis is a disease in which the body's own immune system attacks the liver and causes it to become inflamed.In 2018, the global Autoimmune…- 自己免疫性肝炎治療のグローバル市場：規模・現状・予測2019-2025 Autoimmune Hepatitis is a serious condition that may worsen over time if not treated. Autoimmune Hepatitis can lead to cirrhosis and liver failure.Autoimmune hepatitis is a disease in which the body's own immune system attacks the liver and causes it to become inflamed.In 2018, the global Autoimmune…
- 世界のアルコール性肝炎治療市場規模・現状・予測（2021年-2027年） Alcoholic hepatitis is hepatitis (inflammation of the liver) due to excessive intake of alcohol. It is usually found in association with fatty liver, an early stage of alcoholic liver disease, and may contribute to the progression of fibrosis, leading to cirrhosis. The increasing consumption of alco…
- 世界のB型肝炎治療市場規模・現状・予測（2021年-2027年） It means a treatment of Hepatitis B—— contagious liver infection that can be long lasting. Market Analysis and Insights: Global Hepatitis B Treatment Market The global Hepatitis B Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during…
- B型肝炎治療のグローバル市場：規模・現状・予測2019-2025 It means a treatment of Hepatitis B—— contagious liver infection that can be long lasting. In 2018, the global Hepatitis B Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global He…